Levetiracetam Stadafarma

Levetiracetam, the active ingredient in Levetiracetam Stadafarma, is an anticonvulsant presented as an oral dosage form for systemic use. It is employed in the management of epilepsy, specifically targeting partial‑onset, generalized tonic‑clonic and myoclonic seizures in adult and pediatric patients.

GNH USA supplies Levetiracetam Stadafarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured antiepileptic medicines for diverse healthcare markets, with consistent batch testing, regulatory compliance and on‑time delivery to meet patient needs.

Levetiracetam is an antiepileptic medication that modulates neuronal excitability in seizure disorders.

Partial‑onset seizures: reduces the frequency of focal seizure episodes in patients with epilepsy. Generalized tonic‑clonic seizures: helps prevent convulsive seizures across the whole brain. Myoclonic seizures: diminishes rapid, brief muscle jerks associated with certain epilepsy syndromes.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Somnolence - Fatigue - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, angioedema) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Blood dyscrasias such as neutropenia or thrombocytopenia - Suicidal thoughts or behavior - Severe depression or mood changes - Rash with systemic involvement

Before initiating therapy, consider patient‑specific factors and monitor for potential risks.

Renal impairment: adjust dose based on creatinine clearance. History of psychiatric disorders: monitor mood changes and suicidal ideation. Concomitant CNS depressants: assess for additive sedation. Pregnancy and lactation: evaluate risk‑benefit ratio with a healthcare professional. Store at ambient temperature: keep in original container, protect from moisture and light.

Levetiracetam may interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Phenobarbital: can reduce levetiracetam exposure. - Phenytoin: may decrease levetiracetam levels. - Valproic acid: potential increase in levetiracetam concentration.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be reduced. - Alcohol: may enhance central nervous system depression.